This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
Healthcare ETFs to Buy Ahead of Q3 Earnings
by Sweta Killa
The positive estimate revisions suggest continued outperformance for the healthcare ETFs.
Top-Ranked Healthcare ETFs for Long-Term Investors
by Neena Mishra
Healthcare is now the best-performing sector of 2018. We highlight two top-ranked ETFs suitable for long-term investors.
5 ETFs for a Historically Low August
by Sanghamitra Saha
Trade war talks and faster Fed rate hike concerns may mess with Wall Street in August. These five picks may save investors.
Healthcare ETFs to Buy on Solid Q2 Earnings Expectations
by Sweta Killa
With earnings surprises well in the cards, the healthcare sector is expected to witness earnings growth of 9.1% in the second quarter, suggesting continued outperformance for healthcare ETFs.
Healthcare ETFs to Ride on UnitedHealth's Solid Q2 & Outlook
by Sweta Killa
Investors should tap the opportunity with ETFs having the largest allocation to UnitedHealth.
Healthcare ETFs in Focus Following JNJ Q2 Results
by Sweta Killa
Investors should closely watch the movement of the Johnson & Johnson and keep a close eye on ETFs having double-digit allocation to this diversified drug maker.
Want to Tap Merger Mania? Play Top-Ranked Health Care ETFs
by Sanghamitra Saha
What is driving Healthcare merger-mania and how to tap it with ETFs.
Should You Invest in the PowerShares S&P SmallCap Health Care Portfolio (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
Don't Sell in May and Go Away: Follow These ETF Strategies
by Sweta Killa
Investors could follow some ideas that could lead to a winning portfolio during this soft six-month period.
Should You Invest in the PowerShares S&P SmallCap Health Care Portfolio (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
Healthcare ETFs in Focus Post JNJ Q4 Results
by Sweta Killa
Investors should closely watch the movement of the JNJ following Q4 results and keep a close eye on ETFs having double-digit allocation to this diversified drug maker.
Ride on UnitedHealth's Solid Q4 Results With These ETFs
by Sweta Killa
UnitedHealth breezed past the Zacks Consensus Estimate on both the top and the bottom lines as well as raised its full-year outlook, sending shares of UNH to record highs.
Healthcare ETF (VHT) Hits New 52-Week High
by Zacks Equity Research
Healthcare ETF hits a new 52-week high amid strong earnings and talks of bipartisan deal.
6 Sector ETFs Must Buys Now
by Sanghamitra Saha
Which sector ETFs should be top picks now.
Volatility Spikes on Geopolitics: 4 ETF Tactics to Shield
by Sweta Killa
We have highlighted certain ETF techniques that could lead to a winning portfolio amid the heightened geopolitical tension.
J&J Brightens Outlook: Healthcare ETFs in Focus
by Sweta Killa
Johnson & Johnson continued its long streak of earnings beat and offered an upbeat outlook for the full year. However, it lagged our revenue estimate.
How to Build a Winning ETF Portfolio for Second-Half 2017
by Sweta Killa
If we go by history, stocks have generated positive returns in the second half of the year over the past two decades.
Top Ranked Healthcare ETFs for Long Term Investors
by Neena Mishra
Healthcare was the best performing sector in Q2; we discuss the reasons behind the outperformance and the best ETFs for investors.
Top-Ranked Health Care ETFs to Buy Now
by Sweta Killa
After many twists and turns, the strong momentum has started to build up in the healthcare space, pushing many stocks and ETFs to multi-year highs.
Healthcare ETFs in Focus on Obamacare Replacement Plan
by Sweta Killa
House Republicans have released the long-awaited bill to repeal and replace Obama's signature healthcare law last evening. This will unwind much of the law over the next three years.
Trump Set for Maiden Speech to Congress: ETFs in Focus
by Sweta Killa
The President is expected to bring more clarity on promised tax cuts, big spending, and other business friendly policies in his first speech to Congress slated to be held later today.